Anti arrhythmics Flashcards
Classes of Anti arrhythmics
- Class 1A (procainamide)
- Class 1B (lidocaine)
- Class 1C (Flecainide)
- Class 2 - beta blockers (Metoprolol, Propranolol)
- Class 3 - K+ channel blockers (Amiodarone)
- Class 4 - Non DHP Ca2+ channel blockers (Verapamil, Diltiazem)
MOA of Procainamide
Class 1A
Blocks Na+ and K+ channels
Reduces rate of Phase 0 depolarisation → slows the initiation of depolarisation → reduces conductivity and automaticity
Lengthens phase 1-3 → Increase ERP (time where cardiomyocytes cannot undergo another action potential)
Increases APD (action potential duration)
Clinical uses of procainamide
- Supraventricular & Ventricular arrhythmias
- Wolff-Parkinson-White syndrome
Example of Class 1A drugs
Procainamide
MOA of Lidocaine
Class 1B
-Inhibit Na+ channels in purkinje fibres, ventricular myocytes (not atrial)
Not as potent in blocking Na+ channel activity as class Ia
- Reduces rate of Phase 0 rise (though to a smaller extent)
- Shortens phase 3 repolarisation → reduces APD
- Reduces automaticity (little effect on conductivity)
Clinical uses of Lidocaine
- Treating ischaemic arrhythmias
- Treat digoxin toxicity
Example of Class 1B anti arrhythmics
Lidocaine
MOA of Flecainaide
Inhibit Na+ channels in atrial, ventricular myocytes & purkinje fibre cells
Reduce rate of Phase 0 rise
Shortens phase 3 repolarisation
Reduces conductivity and automaticity
No/ little effect on APD/ERP
Clinical uses of Flecainide
Refractory ventricular tachycardia that tends to progress to VF
MOA of Class 2 anti arrhytmics
They are beta blockers
- Reduces phase 4 depolarisation, so that it takes longer before the drug can depolarise again
- Shape of graph does not change as it does not block any channels, but it reduces heart rate and contractility
- Reduces automaticity
- Prolonged AV conduction
- No changes to APD, ERP
Clinical uses of Metoprolol, Propranolol
Tachycardia caused by sympathetic activation
Atrial fibrillation
Reduces sudden arrhythmic death post-MI
Examples of Class 2 anti arrhytmics
Beta blockers - Metoprolol, Propranolol
MOA of Amiodarone
K+ channel blockers –> Prolongs phase 3 repolarisation
Increases ERP and APD
Clinical uses of Amiodarone
- Effective in maintaining normal sinus rhythm in patients with atrial fibrillation
- Effective in the prevention of reentrant ventricular tachycardia
What class of anti arrhytmic is Amiodarone
Class 3 K+ channel blockers